Curtis A. Lachowiez, Joshua F. Zeidner, Jad Othman, Andy Kaempf, Seongseok Yun, Maël Heiblig, Michael Heuser, Rabia Shahswar, Rafael Madero Marroquin, Joseph M. Cannova, Andrius Zucenka, Jennifer Marvin-Peek, Jayastu Senapati, Yasmin Abaza, Alok Swaroop, Irene Zacheo, Federica Monaco, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carré, Gaspar Aspas Requena, Rachel J. Cook, Elie Traer, Jennifer N. Saultz, Jenny O'Nions, Faisal Basheer, John Laurie, Shivani Handa, Eytan M. Stein, Maria R. Baer, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Emily Curran, Ashley Yocum, Ellen Madarang, Naval Daver, Tapan M. Kadia, Giovanni Marconi, Yazan Madanat, Richard Dillon, Courtney D. DiNardo, Ronan Swords, Juan E. Arango Ossa, Justin Watts, Sanam Loghavi, Daniel A. Pollyea, Elsa Bernard. "Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-26-01801